AG0081D1

117976-89-3 | 1H-​Benzimidazole, 2-​[[[4-​(3-​methoxypropoxy)​-​3-​methyl-​2-​pyridinyl]​methyl]​sulfinyl]​-

Chemical structure of 1H-​Benzimidazole, 2-​[[[4-​(3-​methoxypropoxy)​-​3-​methyl-​2-​pyridinyl]​methyl]​sulfinyl]​-, CAS 117976-89-3
AG0081D1
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 117976-89-3
Catalog Number AG0081D1(AGN-PC-0PB8JS)
Chemical Name 1H-​Benzimidazole, 2-​[[[4-​(3-​methoxypropoxy)​-​3-​methyl-​2-​pyridinyl]​methyl]​sulfinyl]​-
IUPAC Name 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole
InChI InChI=1S/C18H21N3O3S/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)
InChI Key YREYEVIYCVEVJK-UHFFFAOYSA-N
MDL Number MFCD00868879
Molecular Formula C18H21N3O3S
Molecular Weight 359.4426
SMILES S(=O)(Cc1c(C)c(OCCCOC)ccn1)c1nc2c([nH]1)cccc2
Synonyms
1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, sodium salt, 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole, Aciphex, dexrabeprazole, E 3810, E3810, LY 307640, LY-307640, LY307640, Pariet, rabeprazole, rabeprazole sodium, Sodium, Rabeprazole, rabeprazole, 117976-89-3, Aciphex, Habeprazole, Pariets, Rabeprazole [INN:BAN], dexrabeprazole, CHEBI:8768, HSDB 7321, Sodium rabeprazole, 2-(((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole, LY307640, 2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole, 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole, 2-(((4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole, AK-55871, 1H-Benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-, C18H21N3O3S, Rabeloc, R-(+)-Rabeprazole, 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, 2-{[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methanesulfinyl}-1H-1,3-benzodiazole, Rabeprazole (INN), Eraloc (TN), Rabeprazole [BAN:INN], UNII-65JK8810RM, UNII-Q9Z21M00M9, rabeprazol, 65JK8810RM, Q9Z21M00M9, 2-[{4-(3-methoxypropoxy)-3-methylpyridin-2-yl}methylsulfinyl]-1H-benzimidazole, 2-{[4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl}-1H-benzimidazole, Rabeprazole, (R)-, Rabeprazole, (S)-, 2--1H-benzimidazole, 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole, LY 307640, AC1L1JGC, Dexrabeprazole [WHO-DD], CHEMBL1219, SCHEMBL23336, MLS001401446, BIDD:GT0019, GTPL7290, DTXSID3044122, CTK8B7559, 2-((R)-((4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole, YREYEVIYCVEVJK-UHFFFAOYSA-N, HMS2052P03, HMS3394P03, BCP06638, HY-B0656, ANW-57672, BDBM50070209, MFCD00868879, STL186112, AKOS015895259, AN-1084, API0004025, CCG-101158, CS-2888, DB01129, MCULE-7848941080, NC00408, PB21725, KS-000008V4, NCGC00388029-07, ACM117976893, AS-34993, BC208316, CC-08451, CPD000469174, SAM001246619, SC-17337, SMR000469174, SBI-0206867.P001, AB0107093, AX8016918, DB-020298, LS-172365, RT-015337, ST2409233, FT-0602569, C07864, D08463, Q-1236, AB00698237-06, 976R893, A803856, C-20874, SR-01000763041, I06-0755, J-003691, SR-01000763041-3, BRD-A39390670-236-04-0, (S)-2-(((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzimidazole, 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, (R)-, 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, (S)-, 1H-Benzimidazole, 2-((S)-((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, 2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methane}sulfinyl)-1H-1,3-benzodiazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]-methyl] sulfinyl]-1H-benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]-methyl]sulfinyl]-1H-benzimidazole, 2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methylsulfinyl]-1H-benzimidazole, 2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]-1H-benzimidazole, 2-[[4-(3-methoxypropoxy)-3-methyl-pyridin-2-yl]methylsulfinyl]-1H-benzimidazole, 2-{[(3-Methyl-4-(3-methoxypropoxy)-2-pyridinyl)methyl]sulphinyl}-1H-benzimidazole, 2-{[(3-Methyl-4-(3-methoxypropoxy)-2-pyridinyl)methyl]sulphinyl}1H-benzimidazole, 2-{4-(3-Methoxypropoxy)-3-methylpyridine-2-yl}methylsulfinyl-1H-benzimidazole, Pariet, Rebeprazole sodium, pariprazole, CLOFEZONE, Eraloc, RABEPRAZOLE SODIUM, irsogladine maleate, Aciphex (TN), Pariet (TN), Rablet (TN), Rabeprazole sodium salt, D0KL4J, UNII-32828355LL, CID5029, LY-307640, C18-H21-N3-O3-S, ACN-039994, CL23619, CS-O-05154, 32828355LL, E3810, E 3810, E-3810, C063129, 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole, 117976-90-6, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole, 177795-59-4, 177795-60-7, 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, sodium salt,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited